Tevogen Bio Holdings Statistics
Total Valuation
TVGN has a market cap or net worth of $200.44 million. The enterprise value is $202.05 million.
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025, before market open.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TVGN has 183.89 million shares outstanding. The number of shares has increased by 492.57% in one year.
| Current Share Class | 183.89M |
| Shares Outstanding | 183.89M |
| Shares Change (YoY) | +492.57% |
| Shares Change (QoQ) | -37.31% |
| Owned by Insiders (%) | 87.62% |
| Owned by Institutions (%) | 1.94% |
| Float | 22.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -30.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.26
| Current Ratio | 0.26 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -291.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -746.67% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 959.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$570,761 |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.00% in the last 52 weeks. The beta is -0.80, so TVGN's price volatility has been lower than the market average.
| Beta (5Y) | -0.80 |
| 52-Week Price Change | +9.00% |
| 50-Day Moving Average | 1.09 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 53.95 |
| Average Volume (20 Days) | 1,585,346 |
Short Selling Information
The latest short interest is 3.22 million, so 1.75% of the outstanding shares have been sold short.
| Short Interest | 3.22M |
| Short Previous Month | 1.46M |
| Short % of Shares Out | 1.75% |
| Short % of Float | 14.14% |
| Short Ratio (days to cover) | 2.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.56M |
| Pretax Income | -51.21M |
| Net Income | -10.27M |
| EBITDA | -53.40M |
| EBIT | -53.56M |
| Earnings Per Share (EPS) | -$0.07 |
Full Income StatementBalance Sheet
The company has $1.28 million in cash and $2.89 million in debt, giving a net cash position of -$1.60 million or -$0.01 per share.
| Cash & Cash Equivalents | 1.28M |
| Total Debt | 2.89M |
| Net Cash | -1.60M |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | -6.67M |
| Book Value Per Share | -0.09 |
| Working Capital | -6.68M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.00M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |